Vir Biotechnology, Inc. (VIR)
10.29
+0.28
(+2.80%)
USD |
NASDAQ |
May 06, 16:00
10.43
+0.14
(+1.36%)
Pre-Market: 08:25
Vir Biotechnology Free Cash Flow : -396.61M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Hims & Hers Health, Inc. | 57.42M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| BioMarin Pharmaceutical, Inc. | 759.12M |
| Gossamer Bio, Inc. | -171.34M |
| Sensei Biotherapeutics, Inc. | -22.40M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -25.88M |
| Cash from Investing (Quarterly) | 86.65M |
| Cash from Financing (Quarterly) | 1.039M |
| Free Cash Flow Per Share (Quarterly) | -0.1883 |
| Free Cash Flow to Equity (Quarterly) | -23.90M |
| Free Cash Flow to Firm (Quarterly) | -26.22M |
| Free Cash Flow Yield | -27.83% |